Biologic Therapy for Moderate to Severe Psoriasis. Real-World Follow-up of Patients Who Initiated Biologic Therapy at Least 10 Years Ago

INTRODUCTION: The aim of this study was to evaluate response and drug survival of biologic therapy in patients with moderate to severe plaque-type psoriasis who initiated biologic therapy at least 10 years ago, in a real-world setting. METHODS: This was an observational retrospective follow-up study...

Descripción completa

Detalles Bibliográficos
Autores principales: Elberdín, Laida, Fernández-Torres, Rosa M., Paradela, Sabela, Mateos, María, Blanco, Eva, Balboa-Barreiro, Vanesa, Gómez-Besteiro, María I., Outeda, Maria, Martín-Herranz, Isabel, Fonseca, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941069/
https://www.ncbi.nlm.nih.gov/pubmed/35226302
http://dx.doi.org/10.1007/s13555-022-00693-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941069/
https://www.ncbi.nlm.nih.gov/pubmed/35226302
http://dx.doi.org/10.1007/s13555-022-00693-2

Ejemplares similares